BEST UNLIMITED TURBO LONG CERTIFICATE - JOHNSON & JOHNSON Stock

Certificat

2G99S

DE000SW8N8G7

Market Closed - Euronext Paris 12:30:00 2024-05-15 EDT
9.49 EUR +1.71% Intraday chart for BEST UNLIMITED TURBO LONG CERTIFICATE - JOHNSON & JOHNSON
Current month+10.53%
1 month+2.49%
Date Price Change
24-05-15 9.49 +1.71%
24-05-14 9.33 +0.32%
24-05-13 9.3 +1.86%
24-05-10 9.13 -0.22%
24-05-09 9.15 +0.77%

Real-time Euronext Paris

Last update May 15, 2024 at 12:30 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying JOHNSON & JOHNSON
IssuerLogo Issuer Société Générale Société Générale
2G99S
ISINDE000SW8N8G7
Date issued 2024-04-08
Strike 101 $
Maturity Unlimited
Parity 5 : 1
Emission price 9.82
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 9.87
Lowest since issue 8.23

Company Profile

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Sector
-
More about the company

Ratings for Johnson & Johnson

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Johnson & Johnson

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
151.4 USD
Average target price
173.3 USD
Spread / Average Target
+14.46%
Consensus
  1. Stock Market
  2. Certificates
  3. 2G99S Certificat
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW